These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Indications for L-5-hydroxytryptophan in neurology]. Uldry PA; Regli F Rev Med Suisse Romande; 1987 Sep; 107(9):703-7. PubMed ID: 2962265 [No Abstract] [Full Text] [Related]
44. [Myoclonic spasms: their clinical and neurophysiological characteristics, aetiology and treatment]. Erro ME; Navarro MC Rev Neurol; 2009 Jan; 48 Suppl 1():S1-6. PubMed ID: 19222008 [TBL] [Abstract][Full Text] [Related]
45. The proposed role of neurotransmitter receptors in the pathophysiology of human myoclonic disorders. Pranzatelli MR Med Hypotheses; 1989 Sep; 30(1):55-60. PubMed ID: 2571916 [TBL] [Abstract][Full Text] [Related]
46. [Pharmacologic analysis of a new case of postanoxic intention and action myoclonus]. Lhermitte F; Marteau R; Degos CF Rev Neurol (Paris); 1972 Feb; 126(2):107-14. PubMed ID: 4654779 [No Abstract] [Full Text] [Related]
50. Palatal myoclonus: treatment with 5-hydroxytryptophan and carbidopa. Bhatt M; Snow B; Varelas M; Calne D Mov Disord; 1990; 5(4):339-40. PubMed ID: 2259361 [No Abstract] [Full Text] [Related]
51. [Observations on the use of 5 HTP in clinical medicine]. Sabouraud O; Chatel M; Badiche A; Chauvel P; Le Clec'h G Rev Neurol (Paris); 1972 Aug; 127(2):320-3. PubMed ID: 4542329 [No Abstract] [Full Text] [Related]
53. The pathophysiology and pharmacology of photic cortical reflex myoclonus. Artieda J; Obeso JA Ann Neurol; 1993 Aug; 34(2):175-84. PubMed ID: 8101703 [TBL] [Abstract][Full Text] [Related]
54. 5-Hydroxytryptophan-induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus. Klawans HL; Goetz C; Weiner WJ Neurology; 1973 Nov; 23(11):1234-40. PubMed ID: 4147723 [No Abstract] [Full Text] [Related]
55. Treatment of myoclonus with L-5-hydroxytryptophan and carbidopa: clinical, electrophysiological, and biochemical observations. Thal LJ; Sharpless NS; Wolfson L; Katzman R Ann Neurol; 1980 Jun; 7(6):570-6. PubMed ID: 6969054 [TBL] [Abstract][Full Text] [Related]
56. [A case of opsoclonus-polymyoclonia syndrome--suppression by TRH and 5-hydroxytryptophan]. Hashiba Y; Kuroda Y; Neshige R; Shibasaki H Rinsho Shinkeigaku; 1984 Nov; 24(11):1091-4. PubMed ID: 6440724 [No Abstract] [Full Text] [Related]
58. [Serotoninergic conception of myoclonic syndromes. (Review)]. Levin SL Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(6):797-803. PubMed ID: 224629 [No Abstract] [Full Text] [Related]
59. Letter: L 5-Hydroxytryptophan and mood. Trimble M; Chadwick D; Reynolds EH; Marsden CD Lancet; 1975 Mar; 1(7906):583. PubMed ID: 47066 [No Abstract] [Full Text] [Related]
60. [Use of levetiracetam in the management of post-anoxic myoclonias. A report of two cases]. Lay-Son Rivas L; Pizarro Segura J; Meza Flores R Neurologia; 2007 Dec; 22(10):915-6. PubMed ID: 18040909 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]